1[1]Maseri A. Inflammation,atherosclerosis,and ischemic events-exploring the hidden side of the moon [J]. N Eng J Med, 1997, 336: 1 014-021
2[2]Anderson JL, Carlquist JF, Joseph B, et al. Evaluation of C-reactive protein,an inflammation marker, and infectious serology as risk factor for coronary arter disease and myocardial infarction [J]. JACC, 1998, 32: 35-46
3[3]Haverkate F, Thompson SG, Pyke S, et al. Production of C-reactive prot ein and risk of coronary events in stable angina and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group [J]. Lancet, 1997, 349: 462-473
4[4]David M, Nader F, Elliott M, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with tropnin T in acute coronary syndromes:a TIMI 11A substudy [J]. JACC, 1998, 31: 1 460-472
5[5]Luigi M, Biasucci, Giovanna Liuzzo, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrect in stability [J]. Circulation, 1999, 99: 855-923
6[6]Fagerberg B, Gnarpe H, et al. Chlamydia pneumoniae but not cytomegalo virue antibodies are association with future risk of stroke and cardiovascular disease:a prospective study in middle-agedly men with treated hypertension [J]. Stroke, 1999, 30: 299-305
7[7]Sessa R, Di Pietro, Santion I, et al. Chlamydia pneumoniae infection and atherosclerosis coronary disease [J]. Am Heart J, 1999, 137: 116-119
8[8]Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forme of cardiovascular disease [J]. J Am Coll Cardiol, 1996, 27: 1 555-561
9[9]Ridker PM, Kundsin PB, Stampfer MJ, et al. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction [J]. Circulation, 1999, 99: 1 161-164
10[10]Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes:ROXIS pilot study [J]. Lancet, 1997, 350: 404-407
